Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 1
2001 1
2004 1
2006 1
2008 1
2010 1
2012 2
2013 4
2014 5
2015 7
2016 5
2017 10
2018 10
2019 6
2020 8
2021 7
2022 7
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Rationale for combined therapies in severe-to-critical COVID-19 patients.
Gonzaga A, Andreu E, Hernández-Blasco LM, Meseguer R, Al-Akioui-Sanz K, Soria-Juan B, Sanjuan-Gimenez JC, Ferreras C, Tejedo JR, Lopez-Lluch G, Goterris R, Maciá L, Sempere-Ortells JM, Hmadcha A, Borobia A, Vicario JL, Bonora A, Aguilar-Gallardo C, Poveda JL, Arbona C, Alenda C, Tarín F, Marco FM, Merino E, Jaime F, Ferreres J, Figueira JC, Cañada-Illana C, Querol S, Guerreiro M, Eguizabal C, Martín-Quirós A, Robles-Marhuenda Á, Pérez-Martínez A, Solano C, Soria B. Gonzaga A, et al. Among authors: poveda jl. Front Immunol. 2023 Sep 11;14:1232472. doi: 10.3389/fimmu.2023.1232472. eCollection 2023. Front Immunol. 2023. PMID: 37767093 Free PMC article. Review.
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gómez-Cebrián N, Poveda JL, Pineda-Lucena A, Puchades-Carrasco L. Gómez-Cebrián N, et al. Among authors: poveda jl. Cancers (Basel). 2022 Jan 25;14(3):596. doi: 10.3390/cancers14030596. Cancers (Basel). 2022. PMID: 35158864 Free PMC article. Review.
[Risk sharing agreements: with orphan drugs?].
Campillo-Artero C, del Llano J, Poveda JL. Campillo-Artero C, et al. Among authors: poveda jl. Farm Hosp. 2012 Nov-Dec;36(6):455-63. doi: 10.7399/FH.2012.36.6.115. Farm Hosp. 2012. PMID: 23461437 Free article. Review. Spanish.
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A, Falip M, Sánchez-Carpintero R, Abad-Sazatornil MR, Poveda JL, Aibar JÁ, Cardenal-Muñoz E, Aras LM, Sánchez R, Sancho-López A, Trillo-Mata JL, Torrejón M, Gil A. Gil-Nagel A, et al. Among authors: poveda jl. Epilepsy Behav. 2022 Jul;132:108711. doi: 10.1016/j.yebeh.2022.108711. Epub 2022 May 16. Epilepsy Behav. 2022. PMID: 35588562 Free article. Review.
How can artificial intelligence optimize value-based contracting?
Poveda JL, Bretón-Romero R, Del Rio-Bermudez C, Taberna M, Medrano IH. Poveda JL, et al. J Pharm Policy Pract. 2022 Nov 18;15(1):85. doi: 10.1186/s40545-022-00475-3. J Pharm Policy Pract. 2022. PMID: 36401303 Free PMC article.
Pharmacogenomics and the treatment of acute myeloid leukemia.
Megías-Vericat JE, Montesinos P, Herrero MJ, Bosó V, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: poveda jl. Pharmacogenomics. 2016 Jul;17(11):1245-1272. doi: 10.2217/pgs-2016-0055. Epub 2016 Jul 6. Pharmacogenomics. 2016. PMID: 27381050 Review.
A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia.
Megías-Vericat JE, Herrero MJ, Rojas L, Montesinos P, Bosó V, Moscardó F, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: poveda jl. Pharmacogenomics J. 2016 Feb;16(1):30-40. doi: 10.1038/tpj.2015.80. Epub 2015 Dec 8. Pharmacogenomics J. 2016. PMID: 26644203 Review.
69 results